Why Google Keeps Rejecting Your Regen Clinic Ads in 2026 (And the Compliant Fix)

Approximately 58% of first-time healthcare ads are disapproved on initial submission, the highest rejection rate of any advertising vertical on Google. For regenerative medicine clinics, that number is effectively higher because Google’s “Speculative and Experimental Treatment” policy specifically names PRP, stem cell therapy, cellular therapies, and regenerative medicine. Most clinic owners spend weeks troubleshooting ad […]

Exosome Marketing in 2026: What You Can Say, What You Can’t, and Why It Matters

A gloved hand holds a glowing exosome vial next to an FDA guide on a desk, framing compliant exosome marketing

Exosomes are one of the most searched topics in regenerative medicine right now, and one of the most dangerous things a clinic can market. As of 2026, the FDA has issued more than 12 warning letters specifically targeting exosome product marketing. The FTC has permanently banned clinic operators from ever marketing stem cell and exosome […]

Why Your Regen Clinic’s Marketing Is One Word Away From an FDA Warning Letter

A sealed envelope with a red medical wax stamp rests on a dark desk, evoking FDA warning letter risk for a clinic

One word on your website can turn a thriving regenerative medicine practice into an enforcement target. In 2025, the FDA issued over 200 enforcement letters related to deceptive drug advertising, the highest annual total in nearly 25 years. Real clinics received real warning letters for marketing language on their websites and social media. The FTC […]